Reach Us +1-504-608-2390
Adjunctive Role Of Methotrexate In Infectious Uveitis | 651
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Adjunctive role of methotrexate in infectious uveitis

3rd International Conference on Clinical & Experimental Ophthalmology

Ozlem Gurses Sahin

ScientificTracks Abstracts: J Clin Exp Ophthalmol 2013

DOI: 10.4172/2155-9570.S1.008

The purpose of this study is to disclose the adjunctive role of methotrexate for the posterior segment manifestations of FTAABS positive cases and Quantiferon positive cases showing partial resolution with specific therapy. Methods: 3 cases with FTAABS positive, VDRL and HIV negative, and 4 cases with Quantiferon positive and HIV negative status received either oral methotrexate for 6 months or intravitreal methotrexate injections after discontinuation or reduction of specific therapy. Flourescein angiography (FANG) and spectral domain optical coherence tomography (SD OCT)were used for the clinical follow-up. The follow-up period after cessation of methotrexate ranges from 6 months to 3 years. Results: The resolution of posterior segment manifestations both clinically and on FANG and SD OCT were noted. Conclusions: Adjunctive therapy with methotrexate is considered effective for the improvement posterior segment manifestations of FTAABS positive cases and Quantiferon positive cases having partial response to the specific therapy.
Ozlem Gurses Sahin received her M.D. from Hacettepe University Medical Faculty, Ankara, Turkey (1983-1989); she did her Clinical and Research Fellowship in Uveitis and Ocular Immunology (1997-2000) from The University of Illinois at Chicago, Eye and Ear Infirmary Department of Ophthalmology, Chicago, Illinois, USA. Ozlem Gurses Sahin, MD is Specialist in Ophthalmology/Uveitis and Ocular Immunology. She is also a reviewer for the International Journal of Medicine and Medical Science.